# US 2016/0354137 A1 · Transvascular methods of treating extravascular tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354137 A1
- Document ID: US20160354137A1
- Status: Published application
- Kind: A1
- Application number: 15/154,640
- Filed: 2016-05-13
- Published: 2016-12-08
- Earliest claimed: 2012-10-29
- Assignees: Ablative Solutions, Inc.
- Applicants: Ablative Solutions, Inc.
- Inventors: David R. Fischell; Tim A. Fischell; Robert Ryan Ragland; Darrin James Kent; Andy Edward Denison; Eric Thomas Johnson; Jeff Alan Burke; Christopher Scott Hayden
- Web page: https://patentgrep.com/patent/US20160354137A1

## CPC

- A61B 18/04: by heating (by applying electromagnetic radiation A61B18/18)
- A61B 18/00: Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body (eye surgery A61F9/007; ear surgery A61F11/00)
- A61B 18/1477: {Needle-like probes}
- A61B 90/37: {Surgical systems with images on a monitor during operation}
- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61M 25/0084: {being one or more injection needles}
- A61M 25/0108: {using radio-opaque or ultrasound markers}
- A61M 25/04: in the body, e.g. expansible {(A61M25/10, A61M16/0488 take precedence)}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 2018/00166: {Multiple lumina}
- A61B 2018/00285: {Balloons}
- A61B 2018/00351: {Heart}
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61B 2018/00434: {Neural system}
- A61B 2018/00547: {Prostate}
- A61B 2018/00577: {Ablation}
- A61B 2018/046: {in liquid form}
- A61B 2090/3735: {Optical coherence tomography [OCT]}
- A61B 2090/376: {using X-rays, e.g. fluoroscopy}
- A61B 2090/3762: {using computed tomography systems [CT]}
- A61B 2090/378: {using ultrasound}
- A61B 2090/3782: {transmitter or receiver in catheter or minimal invasive instrument}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 2025/0087: {Multiple injection needles protruding laterally from the distal tip}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An intravascular catheter for peri-vascular and/or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand with open ends around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, and/or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The system also includes means to limit and/or adjust the depth of penetration of the ablative fluid into and beyond the tissue of the vessel wall. The preferred embodiment of the catheter includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A percutaneously delivered catheter for peri-vascular fluid delivery outside of an inside surface of a target vessel including:
an outer tube and an outer tube extension section located distal to the outer tube, the outer tube extension section including at least three advanceable needle support elements;
the at least three needle support elements providing centering of the outer tube extension within the target vessel, wherein distal ends of the at least three needle support elements are configured to be the only points of engagement of the outer tube extension section with the inside surface of the target vessel outside of which the peri-vascular fluid delivery occurs, so that no other portion of the outer tube extension section touches the inside surface when the at least three needle support elements touch the inside surface, the catheter having an outside diameter less than an inside diameter of the inside surface of the target vessel to allow blood to flow around the outside of the catheter when the at least three needle support elements are in contact with the inside surface;
at least three needles supported by the at least three needle support elements; and
a control for controlling advancement and retraction of the at least three needles.

### Claim 32 (depends on 31)

The catheter of claim 31, wherein the diameter of the fully expanded at least three needle support elements is between 3-10 mm.

### Claim 33 (depends on 31)

The catheter of claim 31, wherein the diameter of the fully expanded at least three needle support elements is about 8 mm.

### Claim 34 (depends on 31)

The catheter of claim 31, wherein the diameter of the fully expanded at least three needle support elements is greater than the diameter of the diameter of the renal artery.

### Claim 35 (depends on 31)

The catheter of claim 31, wherein the distal ends of the fully expanded at least three needle support elements lie on a plane parallel to the longitudinal axis of the outer tube extension.

### Claim 36 (depends on 31)

The catheter of claim 31, wherein the diameter of each of the fully expanded at least three needle support elements is between 1.5-5 mm.

### Claim 37 (depends on 31)

The catheter of claim 31, wherein the diameter of the fully expanded at least three needle support elements is about 4 mm.

### Claim 38 (depends on 31)

The catheter of claim 31, wherein the at least three needles are configured to be advanced 2-4 mm beyond the distal ends of the fully expanded at least three needle support elements.

### Claim 39 (depends on 31)

The catheter of claim 31, wherein the at least three needles are configured to be advanced 4-8 mm beyond the distal ends of the fully expanded at least three needle support elements.

### Claim 40 (depends on 31)

The catheter of claim 31, wherein each of the at least three needles includes a radiopacity element to provide enhanced radiopacity for the needle.

### Claim 41

A percutaneously delivered catheter for peri-vascular fluid delivery outside of an inside surface of a target vessel including:
an outer tube extension section, the outer tube extension section having at least two advanceable guide tubes;
wherein distal ends of the at least two guide tubes are configured to be the only points of engagement of the outer tube extension section with the inside surface where peri-vascular fluid delivery occurs, so that no other part of the outer tube extension section touches the inside surface when the at least two guide tubes touch the inside surface;
at least two needles supported by the at least two guide tubes, the at least two needles designed to penetrate the inside surface of the target vessel to a pre-determined depth; and
a control for controlling advancement and retraction of the at least two needles, wherein each needle of the at least two needles includes a radiopacity element to provide enhanced radiopacity for the needle.

### Claim 42 (depends on 41)

The catheter of claim 41, wherein the diameter of the fully expanded at least three needle support elements is between 3-10 mm.

### Claim 43 (depends on 41)

The catheter of claim 41, wherein the diameter of the fully expanded at least three needle support elements is about 8 mm.

### Claim 44 (depends on 41)

The catheter of claim 41, wherein the diameter of the fully expanded at least three needle support elements is greater than the diameter of the diameter of the renal artery.

### Claim 45 (depends on 41)

The catheter of claim 41, wherein the distal ends of the fully expanded at least three needle support elements lie on a plane parallel to the longitudinal axis of the outer tube extension.

### Claim 46 (depends on 41)

The catheter of claim 41, wherein the diameter of each of the fully expanded at least three needle support elements is between 1.5-5 mm.

### Claim 47 (depends on 41)

The catheter of claim 41, wherein the diameter of the fully expanded at least three needle support elements is about 4 mm.

### Claim 48 (depends on 41)

The catheter of claim 41, wherein the at least three needles are configured to be advanced 2-4 mm beyond the distal ends of the fully expanded at least three needle support elements.

### Claim 49 (depends on 41)

The catheter of claim 41, wherein the at least three needles are configured to be advanced 4-8 mm beyond the distal ends of the fully expanded at least three needle support elements.

### Claim 50 (depends on 41)

The catheter of claim 41, wherein the radiopacity element is a wire located within a lumen of the at least three needles.
